Decreased levels of SP-A and/or SP-D are also observed in neonates with respiratory distress syndrome (RDS) and patients with idiopathic pulmonary fibrosis, bacterial pneumonia, chronic obstructive pulmonary disease, and asthma (reviewed in [106,107,108]). This evidence concerns the gene SFTPA2 and pulmonary fibrosis.